Intracellular trafficking of the precursor of Spitz (Spi), the major Drosophila EGF receptor (EGFR) ligand, is facilitated by the chaperone Star, a type II transmembrane protein. This study identifies a novel mechanism for modulating the activity of Star, thereby influencing the levels of active Spi ligand produced. We demonstrate that Star can efficiently traffic Spi even when present at sub-stoichiometric levels, and that in Drosophila S 2 R þ cells, Spi is trafficked from the endoplasmic reticulum to the late endosome compartment, also enriched for Rhomboid, an intramembrane protease. Rhomboid, which cleaves the Spi precursor, is now shown to also cleave Star within its transmembrane domain both in cell culture and in flies, expanding the repertoire of known Rhomboid substrates to include both type I and type II transmembrane proteins. Cleavage of Star restricts the amount of Spi that is trafficked, and may explain the exceptional dosage sensitivity of the Star locus in flies.
Introduction
The EGF receptor (EGFR) pathway defines one of the five pathways guiding most of the developmental decisions in Drosophila. It is used repeatedly at various developmental stages, and leads to induction of distinct cell fates depending upon the cell context of activation (Shilo, 2003) . In accordance with the central role of this pathway, mutations in the different components give rise to severe developmental defects at every junction where the pathway is used. Conversely, ectopic activation leads to deleterious consequences as well. Thus, tight regulation of the spatial and temporal pattern of EGFR activation is crucial for all phases of development.
The primary EGFR ligand is Spi, a homologue of mammalian TGF-a (Rutledge et al, 1992) . In contrast to other Drosophila patterning cascades, regulation of EGFR activation does not rely on restricted expression of this activating ligand, but rather on post-translational modification (Schweitzer et al, 1995a) . Spi is broadly expressed throughout development, albeit as an inactive transmembrane precursor (Rutledge et al, 1992) . The mechanism by which this precursor is processed to generate an active, secreted ligand lies at the heart of spatial and temporal regulation of EGFR activation.
A central aspect of Spi processing involves proteolytic cleavage by Rhomboid, a conserved seven-transmembrane domain protein. The catalytic domain of Rhomboid is embedded within the transmembrane domains, leading to intramembrane cleavage of Spi, and release of its extracellular portion from the membrane . Proteolytic cleavage by Rhomboid is specific; to date, the three transmembrane ligands of EGFR (Spi, Keren and Gurken) are the only known Rhomboid substrates in Drosophila (Ghiglione et al, 2002; . Rhomboid uses distinct features in the transmembrane domain of the ligand for recognition and cleavage, most notably helix-breaking residue(s) at the outer third of the transmembrane helix (Urban and Freeman, 2003) . Rhomboid expression is highly dynamic (Bier et al, 1990) , and precisely precedes the pattern of activated MAPK that is induced by EGFR (Gabay et al, 1997) . Ectopic expression of Rhomboid leads to the corresponding activation of EGFR in every tissue, indicating that Rhomboid expression is the limiting component in pathway activation (Golembo et al, 1996) . In addition to Rhomboid (also referred to as Rhomboid-1), which carries out ligand processing in most tissues, two other members of the family have been characterized: Rhomboid-2/Brho/Stet is required in the oocyte and in signaling from germ cells (Guichard et al, 2000; Schulz et al, 2002; Gilboa and Lehmann, 2006) , and Rhomboid-3/Roughoid is required in the eye (Wasserman et al, 2000) .
The recent structural elucidation of the bacterial Rhomboid homologue, GlpG, has shed light on the mechanistic basis for intramembrane proteolysis (Wang et al, 2006; Wu et al, 2006; Ben-Shem et al, 2007) . The catalytic serine is at the top of the fourth transmembrane helix, which does not traverse the bilayer completely. A hydrophilic cavity facing the extracellular side is created, to allow the access of water molecules. It also requires the substrate transmembrane domain to break its helical structure at the top third of the transmembrane domain, in order to fit the protease active site.
Modulating the levels of secreted Spi generated by the signal-producing cells provides a potential mechanism for restricting EGFR activation. Rhomboid levels are unlikely to contribute to such a mechanism, as Rhomboid functions catalytically to cleave Spi . Indeed, although ectopic expression of Rhomboid leads to expansion of the EGFR activation domains, the activation levels are comparable to the endogenous ones. Regulation of intracellular trafficking provides an alternative aspect of Spi processing by which active ligand levels can be controlled. The Spi precursor is produced in excess, but retained in the endoplasmic reticulum (ER) in every cell where it is synthesized. ER retention is an essential aspect, because in its absence, the Spi precursor can reach the plasma membrane, where it is cleaved by nonspecific metalloproteases, which ectopically release an active secreted moiety Reich and Shilo, 2002) . However, maintaining Spi in the ER imposes a constraint on the cells in which normal processing should take place, as Rhomboid resides in a different compartment. When expressed in mammalian cells, Rhomboid proteins localized to the Golgi . Trafficking of Spi is thus essential for cleavage.
Intracellular trafficking of Spi before cleavage is mediated by Star, a type II, single-pass transmembrane protein.
Star associates with Spi and efficiently mediates its trafficking from the ER to the Rhomboid compartment Tsruya et al, 2002) . Star is an exceptionally dosage-sensitive component of the EGFR pathway. Mutations in the Star locus were first identified in 1919 by virtue of the dominant, haploinsufficient phenotype they induce in the eye, leading to rough eyes with a reduced number of photoreceptors in each ommatidium (Bridges and Morgan, 1919; Heberlein and Rubin, 1991; Brown and Freeman, 2003) . Conversely, overexpression of Star leads to extra photoreceptor cells (Hsiung et al, 2001; Tsruya et al, 2002) . Genetic interactions confirmed that these phenotypes are a result of hypo-or hyperactivation of the EGFR pathway, respectively (Kolodkin et al, 1994) .
In the present study, we demonstrate that Star activity is subject to regulation, resulting in restriction of the levels of active Spi ligand generated by the signal-producing cells. Star appears to traffic the Spi precursor while cycling between the ER and late endosomes of Drosophila S 2 R þ cells. A key observation is that Rhomboid, a late endosome resident in these cells, cleaves both the Spi precursor and Star. Cleavage of Star, which occurs within the transmembrane domain, leads to its inactivation as a Spi chaperone. Star cleavage allows for quantitative regulation of Spi trafficking, modulating the level of ligand that is cleaved and secreted.
Results
The trafficked Spi precursor and Rhomboid localize to late endosomes of Drosophila S 2 R þ cells
Compartmentalization, coupled to tight control of intracellular trafficking, was shown to be crucial in the control of Spi processing. Following translation, the Spi precursor is retained in the ER, by COPI-dependent retrograde trafficking (Schlesinger et al, 2004) . Cleavage by the transmembrane protease Rhomboid, generating the active form of Spi, usually takes place in a distinct cellular compartment. Trafficking between the ER and the Rhomboid compartment is mediated by the Star chaperone. In the heterologous COS cells, Spi is trafficked to the Golgi, where it is cleaved by Rhomboid.
To follow this process in native Drosophila S 2 R þ cells, we first set out to define the cellular compartment(s) to which Spi is trafficked by Star. Compartment-specific markers used for this purpose included anti-BiP for the ER, anti-p120 for the Golgi, Rab5-GFP for early endosomes, Rab7-GFP for late endosomes and Rab11-GFP for recycling endosomes. As expected from previous studies, when expressed separately in S 2 R þ Drosophila cells, Spi and Star exhibited a perinuclear and punctate distribution. The perinuclear distribution colocalized with BiP ( Figure 1B and E), and both patterns colocalized with Rab11 ( Figure 1C and F). Upon coexpression with Star, Spi is efficiently translocated from the ER, exhibiting a punctate distribution, with no detectable accumulation on the plasma membrane ( Figure 1G ). The structures harboring trafficked Spi showed significant colocalization with Rab7, a lower level of overlap with Rab5 and no overlap with the Golgi marker ( Figure 1H -J and S). We conclude that Star facilitates trafficking of Spi from the ER to late endosomes in S 2 R þ cells.
Significantly, Rhomboid-1 also localized predominantly to the Rab7 compartment, following its expression in S 2 R þ cells ( Figure 1L -N and S), suggesting that Spi cleavage in Drosophila cells takes place in late endosomes. How does the presence of Rhomboid affect the intracellular distribution of Spi? Comparison of cells expressing Spi and Star in the absence or presence of Rhomboid showed significant accumulation of Spi in the late endosome in both cases ( Figure 1J , R and S). However, in the presence of Rhomboid, low levels of Spi could also be identified in the Golgi ( Figure 1P and S). This may indicate that Spi is secreted by trafficking to the Golgi, following cleavage in the late endosome. Additional trafficking routes through the recycling endosome or directly to the plasma membrane may also be envisaged (Zerial and McBride, 2001; Seachrist and Ferguson, 2003) . 
Rhomboid limits trafficking of Spi by Star
How do different stoichimetric relationships between Spi and Star impinge on trafficking? We transiently transfected varying DNA amounts of Spi and Star into Drosophila S 2 R þ cells, and monitored their intracellular localization. A GFP-Spi fusion construct and HA-tagged Star were used to allow for simultaneous detection of both elements. We found that cotransfection of Spi altered the intracellular distribution of Star in a dose-dependent manner. When transfected at a fivefold excess over Spi, Star remained predominantly in the ER ( Figure 2A ). Raising the relative levels of transfected Spi resulted, however, in a gradual depletion of Star from the ER, and Star was found to colocalize with Spi in a punctate pattern. Intermediate levels of Star were observed in the ER when Star and Spi were transfected in equivalent levels ( Figure 2B ), whereas little or no Star remained in the ER when Spi was transfected at a five-fold excess over Star ( Figure 2C ). These experiments demonstrate that high levels of Spi can alter the intracellular distribution of Star. Complete trafficking of Spi was observed in these cotransfection experiments, even when Spi was in excess. To further characterize the capacity of low levels of Star to traffic Spi, a fixed level of Spi was expressed along with decreasing concentrations of cotransfected Star. Many of the cells continued to exhibit full trafficking of Spi, even when Spi DNA was transfected at a 15-fold excess over Star ( Figure 2D-F) . To verify the stoichiometric ratios between Spi and Star proteins, their levels were compared when both proteins were tagged with HA, and Star-HA was transfected at decreasing DNA concentrations. Star protein levels were lower than those of Spitz when equal DNA amounts were transfected, and were hardly visible upon decreasing the concentration of its DNA ( Figure 2I ). The relative levels of Star protein appear to be even lower than predicted from the DNA ratios. Thus, markedly sub-stoichiometric levels of Star can efficiently traffic Spi. A plausible mechanism may be the recycling of Star from the late endosome to the ER, to traffic additional molecules of Spi.
A marked change in the efficiency of Spi trafficking by low levels of Star was observed upon coexpression of Rhomboid. In many cells, only partial trafficking of Spi was detected, and the majority of Spi molecules were retained in the ER ( Figure 2G ). This effect of Rhomboid on Spi trafficking was quantified ( Figure 2J) . A five-fold excess of Spi over Star could be efficiently trafficked in the absence of Rhomboid, such that in B80% of the cells Spi was fully cleared from the ER. However, in the presence of Rhomboid, efficient trafficking of Spi was achieved in only B50% of the cells. The attenuating effect of Rhomboid was observed only when Star levels were limiting. When Spi and Star were expressed at an equimolar ratio, highly efficient trafficking was obtained, both in the absence or presence of Rhomboid.
Expression of another member of the Rhomboid family, Rhomboid-3, also attenuated the capacity of sub-stoichiometric levels of Star to traffic Spi ( Figure 2H ). Rhomboid-3 was even more efficient than Rhomboid-1 in this regard, reducing for example the percentage of cells displaying complete Spi trafficking at a 5:1 Spi/Star ratio from 80 to 25% ( Figure 2J ). These results demonstrate a significant influence of Rhomboid proteases on the capacity of Star to traffic Spi.
Rhomboid-dependent cleavage of Star
We sought to determine whether the diminished trafficking capacity of Star in Rhomboid-expressing cells was associated with post-translational modifications of the Star protein.
Extracts prepared from Drosophila S2 cells coexpressing Spi, Star and Rhomboid were subjected to Western blot analysis. A Star construct tagged C-terminally with an HA moiety was used and Star expression was monitored using anti-HA antibodies. Star-HA is detected in cell extracts primarily as an B90 kDa band. Coexpression of Rhomboid, however, led to the appearance of a prominent lower molecular weight (B35 kDa) form of Star in the cells, in the presence or absence of Spi ( Figure 3 ). As this form was detected by anti-HA, it represents a C-terminal fragment of Star, and may correspond to the cleaved extracellular domain of this type II transmembrane protein.
Consistent with this interpretation, a similarly sized fragment was also secreted into the medium and detected by anti-HA (Figure 3 ). An efficient cleavage of Star was similarly observed when Rhomboid-3/Roughoid was coexpressed with Star instead of Rhomboid-1 (Figure 3 ). Low levels of the 35 kDa fragment were detected in the absence of transfected Rhomboid, perhaps owing to low levels of endogenous Rhomboid in S2 cells. Interestingly, the apparent Rhomboid-dependent cleavage of Star did not require the presence of Spi (Figure 3 ).
Rhomboid cleaves Star directly
Is Rhomboid the protease directly responsible for Star cleavage? Several approaches were taken to address this critical issue. To assess whether Rhomboid acts catalytically in this context, we examined the level of Star cleavage following dilution of cotransfected Rhomboid. Secreted Star could still be detected in the medium even when the levels of Rhomboid DNA were 5000-fold lower than those of Star ( Figure 4A ). Similar findings were previously reported for cleavage of Spi by Rhomboid . To verify the relative levels of Star and Rhomboid proteins, their expression levels were compared when both were tagged with HA. Although Rhomboid levels were higher than Star following transfection of equal DNA amounts, Rhomboid protein was undetectable (yet functional) when its DNA was 1/50 or less than that of Star ( Figure 4B) .
We repeated the cell-based cleavage assay using a Rhomboid variant in which the active site serine 217 has been mutated . Neither secreted Spi nor secreted Star could be detected in the medium of cells coexpressing Spi and Star with this mutant form of Rhomboid ( Figure 4C ). This set of results is consistent with Rhomboid acting as a proteolytic enzyme in bringing about the cleavage of Star.
Finally, we carried out the Star cleavage assay in a heterologous cell line, reasoning that components required for Star cleavage in addition to Rhomboid may not be conserved. Star tagged with FLAG at the C-terminus was expressed alone or in the presence of Rhomboid-1 or Rhomboid-3 in human 293 cells. The appearance of the cleaved form of Star following coexpression with Rhomboid proteins was observed, both in the cells and in the medium ( Figure 4D ). Taken together, these experiments strongly suggest that cleavage of Star is a direct consequence of proteolysis by Rhomboid.
We carried out mass spectrometric analysis to determine the cleavage site within Star that gives rise to the secreted, 35 kDa form. The cleaved form of Star was purified from the medium of S 2 R þ cells expressing both Rhomboid-3 and a Star construct FLAG-tagged at its C-terminus ( Figure 5A ). Mass spectrometry of proteolytic fragments generated by treatment with chymotrypsin identified several peptides corresponding to the Star extracellular region. The most N-terminal peptide contained residues 298 IVYMoxDTTEIRHQQF 311 corresponding to part of the predicted transmembrane domain of Star ( Figure 5B ). We conclude that the secreted form of Star is generated by intramembrane proteolysis, further supporting the notion of direct cleavage by Rhomboid proteins.
In vivo cleavage of Star by Rhomboids
To monitor the cleavage of Star by Rhomboids in an in vivo setting, we fused the transcriptional reporter LexA-VP16 to the extreme N-terminus of Star. This reporter contains a nuclear-localization signal, and thus, upon cleavage of Star should be targeted to the nucleus. This process can be followed by transcriptional induction of a LexA reporter. Star-LV was expressed in the fly eye by the GMR-Gal4 driver, and Western blot analysis was carried out on adult head extracts. In addition to the full-length protein, a smaller band of B70 kDa was detected by an anti-LexA antibody. The smaller band corresponds in size to the entire cytoplasmic domain of Star with the LexA protein, as the fragment comigrated with a Star-LV construct that was truncated at the putative cleavage site of the Star transmembrane domain ( Figure 6A ).
To test if cleavage of Star could be driven by Rhomboids in vivo, the Star-LV construct was expressed by prd-Gal4, in embryos carrying a lacZ reporter for nuclear LexA-VP16. No reporter expression was detected in the absence of Rhomboid expression ( Figure 6B ). However, when either Rhomboid-1 or Rhomboid-3 was coexpressed with Star-LV in the prd stripe pattern, prominent expression of the reporter was detected ( Figure 6C and D) . Thus, Rhomboid-dependent cleavage of Star can be demonstrated in embryos.
Cleavage disrupts the trafficking capacity of Star
Is there a causal relationship between processing of Star by Rhomboid and attenuation of its ability to efficiently traffic Spi in Rhomboid-expressing cells? To address this issue, we generated HA-tagged constructs that represent the two forms of Star that are produced by cleavage: spStar, in which a signal peptide is attached to the extracellular portion of Star; and Star-NTM, which is composed of the transmembrane and cytoplasmic portions of the protein ( Figure 7A ; Tsruya et al, 2002) .
Both constructs were assayed for their subcellular localization and for their ability to traffic Spi. spStar is secreted to the medium (not shown). Examination of the intracellular localization of spStar demonstrated that it was found only in secretory vesicles and was unable to traffic the Spi precursor, even when expressed in excess ( Figure 7B ). Star-NTM was similarly incapable of trafficking Spi and did not accumulate in the ER ( Figure 7C ). These experiments suggest that the resulting forms of Star produced by Rhomboid cleavage are incapable of undergoing retrograde trafficking and cannot facilitate trafficking of Spi. Cleavage of Star by Rhomboid therefore leads to inactivation of Star.
Discussion
Dynamic and highly regulated activation of the EGFR pathway is essential for the normal development of most, if not all, Drosophila tissues (Shilo, 2003 (Shilo, , 2005 . Spatial and temporal control of ligand processing provides key regulatory mechanisms governing EGFR activation (Schweitzer et al, 1995b) . Most factors involved in EGFR ligand biogenesis are expressed ubiquitously. In contrast, expression of the protease Rhomboid, which cleaves the ligand precursors to yield an active ligand, is tightly regulated and highly dynamic, and corresponds to the resulting pattern of EGFR activation (Gabay et al, 1997) . Rhomboid thus serves as a limiting factor in this process. Rhomboid functions in an enzymatic, sub-stoichiometric manner. In cell culture, even minute Protein levels of Star and Rho, both tagged with HA, were compared following transfection of equal DNA levels. Rho protein levels were higher under these conditions. Nevertheless, when Rho DNA was diluted 1/50 or more, it was no longer detected. Rho appeared as a higher molecular weight doublet owing to multimerization in the sample of the protein, which contains multiple TM domains. (C) To test if the enzymatic properties of Rhomboid are necessary for Star cleavage, we expressed Star with a mutated form of Rhomboid (MR), that is deficient in proteolytic activity. The cleaved and secreted forms of Spi and Star, which are readily generated in the presence of intact Rhomboid-1 (R1), could not be detected under these circumstances. (D) To examine the possibility of direct cleavage of Star by Rhomboid, Star-FLAG was expressed in human 293 cells. In the presence of Rhomboid-1 (R1) or Rhomboid-3 (R3), Star underwent cleavage and secretion into the medium of this heterologous cell line, implying direct cleavage by Rhomboid.
amounts of Rhomboid can efficiently cleave the EGFR ligands . In flies, however, overexpression of Rhomboid does not lead to levels of EGFR activation that are higher than the endogenous ones, as measured by dpERK accumulation (not shown). Thus, although Rhomboid expression strictly determines the spatial and temporal onset patterns of EGFR pathway activation, the extent of pathway activity cannot be controlled by regulating Rhomboid levels.
The instructive and pleiotropic roles of EGFR go hand in hand with the necessity to restrict the spatial spreading of this activation, to induce the correct number of cells in each instance. In the cells receiving the EGFR signal, several inducible mechanisms account for the spatial restriction of signal spreading. They include Argos, a secreted inhibitor that itself is a target gene for the pathway. Although Argos is induced only in cells receiving maximal EGFR activation, it is a secreted protein that may exert its effect several cell diameters away from its site of production. Two additional negative regulators function in a cell-autonomous manner, and are induced in a broader domain than argos. Kekkon is a transmembrane protein that forms nonfunctional heterodimers with EGFR, and Sprouty is a cytoplasmic protein that interferes with the Ras signaling pathway. Mutants for Figure 5 The site of Star cleavage within its transmembrane domain. (A) Star-FLAG was overexpressed together with Rhomboid-3 in Drosophila S2 cells. The medium was collected and purified by anti-FLAG immunoprecipitation. Following elution and SDS-PAGE electrophoresis, the purified secreted Star (sStar) was digested and the resulting peptides analyzed by mass spectrometry. (B) Within the protein sequence of Star, the predicted transmembrane domain is marked in yellow. The identified peptides are marked in red, including the most N-terminal one, which includes part of the transmembrane domain, indicating that the cleavage site lies within the transmembrane domain. (C) Alignment of the Spi and Star transmembrane domains, according to their orientation in the membrane. Similar to Spi, Star contains a helix-breaking residue (red) in the top third of its transmembrane domain, which is compatible with intramembrane proteolysis by Rhomboids. Helixforming residues are marked in black, helix-breaking residues in red, and others in green. these negative regulators exhibit an expansion of the domain of EGFR activation (Shilo, 2003) .
We examined whether the cells that produce the active ligand also contribute to restriction of the spatial domain of EGFR activation, by limiting the amount of secreted ligand produced. We focused on Spi, which is the primary ligand throughout development. The levels of Spi precursor that are produced do not seem to play a role in this regulation, as overexpression of Spi does not yield any phenotypes . Several mechanisms that efficiently cope with excess levels of Spi have been identified. First, the Spi precursor is retained in the ER, preventing its unregulated cleavage by fortuitous proteases in cells which do not express Rhomboid. Second, Spi is labile, such that even high levels of expression of a GFP-tagged ligand were difficult to visualize in embryos (Tsruya et al, 2002) .
The levels of the active ligand, cleaved Spi (cSpi), provide an alternative and attractive target for controlling the extent of pathway activation by the signal-producing cells. A likely candidate for controlling the level of cSpi is Star, as it forms protein-protein interactions with Spi and allows its trafficking to the site of processing Tsruya et al, 2002) . Furthermore, the levels of Spi protein are reduced in clones lacking Star, suggesting that Star stabilizes Spi (Hsiung et al, 2001) . Finally, Star is known to be the element most sensitive to dosage alterations in the EGFR pathway. Mutations in Star have been identified multiple times in genetic screens, which rely on dosage sensitivity. In fact, the original dominant, haploinsufficient phenotype of Star in the eye relies on its dosage sensitivity. Conversely, overexpression of Star yields a dramatic EGFR hyperactivation phenotype in the same tissue (Hsiung et al, 2001; Tsruya et al, 2002) . This work explored the involvement of Star in regulating the levels of cSpi that are released by the producing cells.
Star traffics Spi to a 'dead end' compartment
In contrast to the highly restricted and regulated expression of Rhomboid during development, the expression of Spi and Star is broad. Although the trafficking role of Star is crucial to allow Spi to reach the Rhomboid compartment, in cells that do not express Rhomboid, the ubiquitous coexpression of Spi and Star poses a problem. Once Spi is allowed to exit the ER, fortuitous cleavage on the plasma membrane may generate low levels of active ligand. Coexpression of Spi and Star in Drosophila cells, however, resulted in efficient accumulation of Spi in a punctate cytoplasmic distribution, but not on the plasma membrane (Tsruya et al, 2002) . Examination of colocalization with several compartment markers identified this structure as the late endosome. Once trafficked to the late endosomal compartment, the degradation route of the Spi precursor is not known. We failed to see significant colocalization of Spi with a lysosomal marker (not shown), but this may stem from rapid degradation in the lysosome.
Expression of Rhomboid-1 in S 2 R þ cells demonstrated that the protein accumulates in a punctate structure that again corresponds to the late endosome. These results are different from the localization of Rhomboid in the Golgi upon expression in heterologous COS cells . As we have localized Rhomboid in Drosophila cells, the compartment identified here may be physiologically more relevant. In view of the potent enzymatic activity of Rhomboid, we cannot exclude, however, the possibility that the action of Rhomboid is effectively manifested in a compartment where it is not abundant, such as the Golgi. Cleavage of Spi by Rhomboid may thus be executed either in the Golgi en route to the late endosome, or in the late endosome, where the Spi/Star complex, as well as Rhomboid, are primarily localized. If Spi is cleaved in the late endosome, there are several routes that may mediate its secretion, including Rab9-mediated trafficking to the Golgi, trafficking to the recycling endosome or direct Rab4-mediated trafficking to the plasma membrane (Zerial and McBride, 2001; Seachrist and Ferguson, 2003) . The kinetics of each of these steps may be different.
Star is cleaved by Rhomboids
We have identified an efficient cleavage of Star that is mediated by Rhomboid. This process does not require Spi, and leads to the secretion of the entire extracellular domain of Star. Cleavage of Star is performed efficiently even when Rhomboid is present at highly sub-stoichiometric levels, it requires an intact active site of the Rhomboid protease, and is executed in the presence of either Rhomboid-1 or Rhomboid-3. The ability to recapitulate Star cleavage in the heterologous 293 human cell line and the identification of the cleavage site within the Star transmembrane domain strongly suggest that cleavage by Rhomboid is direct.
These findings are surprising for several reasons. All intramembrane proteases identified to date, including Presenillin, Site-2 protease, Rhomboid and Signal peptide peptidase, were thought to recognize either type I or type II transmembrane targets Wolfe and Kopan, 2004) . The capacity of Rhomboids to cleave not only EGFR ligands, which are type I proteins, but also a type II protein such as Star significantly widens its substrate recognition spectrum. The recently published crystal structures of GlpG, a Rhomboid protease from Escherichia coli, suggest possible mechanisms by which Rhomboid substrates might gain access to the protease active site (Wang et al, 2006; Wu et al, 2006; Ben-Shem et al, 2007) . The structures clearly show that only individual transmembrane helices can potentially enter the active site. However, no specific restriction can be derived from these structures as to the orientation of the substrate in the membrane. As the structures do not impose substrate directionality, it is plausible that type II transmembrane proteins can also enter the active site, provided that they contain appropriate residues, that confer flexibility at the external third part of their transmembrane helix, as has been demonstrated for the type I transmembrane proteins (Urban and Freeman, 2003) . In this regard, both Spitz and Star contain residues that might confer helical fragility at the appropriate location ( Figure 5C ).
Biological consequences of Star cleavage
Modulation of chaperone proteins may provide an effective way to regulate protein trafficking. A prominent example is provided by the SCAP chaperone, which traffics the transcription factor SREBP between cellular compartments in response to changes in sterol levels (Yang et al, 2002) . High sterol levels facilitate the association between SCAP and the INSIG-1 protein, and compromise the trafficking ability of SCAP. Cleavage of Star may represent an alternative mean to modulate chaperone activity. In this case, modulation is not
